KOMOTINI, Greece – Prime Minister Kyriakos Mitsotakis paid a visit to the Pharmathen pharmaceuticals production facilities in Sapes, Rodopi, in northern Greece on Tuesday afternoon, as part of the government’s recognition of every innovative business initiative.

He was accompanied by his spouse, Mareva Grabowski-Mitsotaki, and both were given a tour of the facilities by board member Vassilis Katsos.

In comments at the pharmaceutical company, the prime minister said that the government was particularly intent on providing additional incentives to the pharma sector, “allowing the combination of clawback with productive investments.”

“Successful enterprises are not judged by the results of their balance sheets alone,” Mitsotakis said, “or their profits, or the dividents paid out to their shareholders. They are identified mainly with the confidence with which employees themselves fully support the business effort. There is no successful company, in my opinion, without satisfied employees, who feel they contribute to the greater good of the company and to their own personal progress.”

Pharmathen’s plan includes investments of over 250 million euros to 2024, of which 200 mln are allocated to this particular facility the premier visited. Annually, the company produces 3 billion pills and 2 billion capsules, and in 2020, its sales are expected to reach 260.6 mln euros, a growth of 17 pct over 2019 figures. The multinational is entirely focused on exports, while the Rodopi plant employees 36 pct of the company’s entire force.